Experience World-Class Beauty & Medical Care in Korea

Minimally Invasive Glaucoma Post-Op Care Program in korea

Minimally Invasive Glaucoma Post-Op Care Program

Treatment Overview

The Minimally Invasive Glaucoma Post-Op Care Program in Korea is a specialized follow-up system designed to ensure optimal healing, stable intraocular pressure (IOP), and long-term surgical success after Minimally Invasive Glaucoma Surgery (MIGS). Korea is internationally recognized for its highly structured, technology-enhanced post-operative care that supports patients who undergo procedures such as:

  • iStent Inject / iStent W
  • Hydrus Microstent
  • Kahook Dual Blade (KDB) Goniotomy
  • GATT (Gonioscopy-Assisted Transluminal Trabeculotomy)
  • Canaloplasty (manual or microcatheter-assisted)
  • Trabecular micro-bypass procedures
  • Combined Cataract + MIGS surgeries

This program focuses on early inflammation control, monitoring for pressure fluctuations, verifying implant position, and ensuring long-term improvement in aqueous outflow.


Purpose & Benefits

Purpose

  • Support safe and rapid recovery after MIGS
  • Monitor early and long-term IOP changes
  • Detect complications such as hyphema, inflammation, or implant issues
  • Guide medication tapering after surgery
  • Ensure stability of the trabecular drainage system
  • Enhance long-term success through structured follow-ups

Benefits

  • Faster recovery compared to traditional glaucoma surgeries
  • Reduced inflammation and improved healing
  • Early detection of pressure spikes or complications
  • Precise monitoring with OCT, gonioscopy, and digital imaging
  • Lower medication burden thanks to MIGS effectiveness
  • Higher long-term safety with minimal tissue disruption
  • Optimized surgical outcomes through consistent care

Ideal Candidates

The Minimally Invasive Glaucoma Post-Op Care Program in Korea is ideal for:

  • Patients who recently underwent any MIGS procedure
  • Individuals with combined cataract + MIGS surgeries
  • Patients prone to inflammation or IOP fluctuations
  • Those with normal-tension glaucoma requiring careful vascular monitoring
  • Patients with early, moderate, or medication-dependent glaucoma
  • Individuals needing structured recovery guidance and close follow-up

Possible Risks & Complications

While MIGS procedures are considered very safe, the post-operative period may involve:

  • Mild inflammation
  • Transient hyphema (blood in the anterior chamber)
  • Temporary blurring or glare
  • IOP spikes or insufficient lowering
  • Malposition or obstruction of stents (rare)
  • Dryness or irritation from post-op drops

Korean specialists minimize risks through:

  • AI-assisted IOP prediction and monitoring
  • Precise medication tapering schedules
  • OCT and gonioscopic verification of implant position
  • Early-intervention strategies to stabilize outflow
  • Tailored anti-inflammatory protocols

Surgical Techniques

(These techniques are monitored and managed during post-op care.)

1. iStent Inject / iStent W

Post-op checks ensure proper placement and unobstructed flow.

2. Hydrus Microstent

Surgeons evaluate stent position and Schlemm’s canal opening integrity.

3. KDB Goniotomy

Angle healing and trabecular meshwork opening are regularly assessed.

4. GATT

Post-op care focuses on hyphema resolution and canal healing.

5. Canaloplasty

Monitoring includes canal dilation stability and suture/tension integrity.

6. Combined Cataract + MIGS

Coordinated care ensures both IOL and MIGS outcomes remain stable.


Treatment Process in Korea

Step 1 – Immediate Post-Op Assessment (Day 1)

Includes IOP measurement, anterior chamber evaluation, and implant verification.

Step 2 – Early Follow-Up (Week 1)

Monitoring inflammation, early healing, and pressure response to surgery.

Step 3 – Short-Term Monitoring (1–3 Months)

OCT, gonioscopy, and IOP checks to ensure stable trabecular outflow.

Step 4 – Medication Adjustment

Gradual reduction of anti-inflammatory and anti-glaucoma drops based on IOP trends.

Step 5 – Long-Term Stabilization (3–12 Months)

Ensuring MIGS remains effective and preparing long-term monitoring schedules.

Follow-Up Schedule:
Day 1 → Week 1 → Month 1 → Month 3 → Month 6 → Month 12 → Annually

Setting: Outpatient glaucoma post-op care center


Recovery & After-Care

After-Care Guidelines

  • Use prescribed post-op drops exactly as instructed
  • Avoid rubbing the eye for at least 2 weeks
  • Avoid heavy lifting, bending, or strenuous activity
  • Wear protective eyewear outdoors
  • Do not swim or expose eyes to water for 1–2 weeks
  • Attend all scheduled IOP and implant checks
  • Report symptoms such as pain, halos, or sudden vision changes

Recovery Timeline

Day 1–3: Mild irritation or blurring improves
Week 1: Inflammation decreases; IOP patterns become clearer
Weeks 2–4: Vision stabilizes; medication tapering may begin
1–3 Months: MIGS effect fully measurable
3–12 Months: Long-term stability confirmed


Results & Longevity

Expected Results

  • Stable, sustained IOP reduction
  • Reduced need for glaucoma medications
  • Improved drainage function without major tissue damage
  • Faster return to normal activities
  • Long-term stabilization of optic nerve and visual fields

Longevity

  • MIGS benefits often last years, depending on glaucoma severity
  • Long-term success improves with proper post-op care
  • Regular monitoring prevents late complications
  • Many patients maintain reduced medication use over time

Why Korea Is a Top Destination

  • Leading MIGS expertise with high surgical success rates
  • Advanced imaging systems for post-op implant evaluation
  • AI-assisted monitoring for pressure and healing patterns
  • Highly structured recovery schedules
  • Superior infection control and patient comfort systems
  • Extensive experience with combined cataract + MIGS surgery

Unique Korean Innovations

  • AI-based IOP stabilization prediction
  • Gonioscopic digital mapping for implant verification
  • Microvascular flow analysis after MIGS
  • Customized anti-inflammatory micro-dosing strategies
  • Post-op digital monitoring apps for symptoms & drop schedules
  • Hybrid post-op care combining in-clinic and telemedicine monitoring

These innovations make Korea’s
Minimally Invasive Glaucoma Post-Op Care Program
one of the most advanced healing and stabilization systems for MIGS patients worldwide.


Cost Range (Indicative Estimate)

Program PackagePrice (KRW)Approx. USDInclusions
Basic MIGS Post-Op Check₩80,000 – ₩150,000~$60 – $110IOP check + basic evaluation
Advanced MIGS Post-Op Monitoring₩250,000 – ₩500,000~$190 – $380OCT + gonioscopy + AI IOP trend analysis
Comprehensive MIGS Long-Term Care Program₩700,000 – ₩1,500,000+~$520 – $1,150+Full imaging + personalized medication plan + long-term monitoring

Popular Clinics in Korea

  • B&VIIT Eye Center (Seoul)
  • Dream Eye Center (Seoul)
  • BGN Eye Clinic (Seoul & Busan)
  • Glory Seoul Eye Clinic
  • K-Cure Vision Center (Gangnam)

Get Consultancy

More insights

Testosterone Replacement for Libido Enhancement in Korea

Treatment Overview Testosterone Replacement Therapy (TRT) for Libido Enhancement is a medical treatment designed to restore testosterone levels in men experiencing low sexual desire due to hormonal deficiencies. The therapy helps improve sexual desire, arousal, and overall sexual performance, and can be administered via injections, gels, creams, patches, or nasal applications depending on clinical evaluation and patient preference. → Personalized hormone therapy targeting libido.→ Multiple

Read more >

Testosterone Replacement for Muscle Loss in Korea

Treatment Overview Testosterone Replacement Therapy (TRT) for Muscle Loss is a medical treatment designed to restore testosterone levels in men experiencing age-related or hormone-related muscle atrophy. The therapy helps increase muscle mass, improve strength, and enhance physical performance, and can be administered via injections, gels, creams, patches, or nasal applications depending on patient preference and clinical requirements. → Personalized hormone therapy targeting muscle loss.→ Multiple

Read more >

Testosterone Replacement for Osteoporosis in Korea

Treatment Overview Testosterone Replacement Therapy (TRT) for Osteoporosis is a medical treatment designed to restore testosterone levels in men with low hormone levels, helping to strengthen bones, improve bone density, and prevent fractures. This therapy can be administered via injections, gels, creams, patches, or nasal applications, depending on patient preference and clinical requirements. → Personalized hormone therapy targeting bone health.→ Multiple delivery options for convenience

Read more >